US – Federal: The US Food and Drug Administration (FDA) has received numerous comments from a variety of industry members about certain aspects of its Tobacco Program. Many of the comments claim that the regulatory agency has not convened its own group of scientific advisors in nearly four years and makes decisions based on political agenda and not the science » Continue Reading.
I'm already a subscriber

Our Key Benefits

The global novel nicotine market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

TobaccoIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organisation